Skip to content

A study on the activity and QOL of patients prescribed Long Term Oxygen Therapy which includes a transportable oxygen concentrator.

A study on the activity and QOL of patients prescribed Long Term Oxygen Therapy which includes a transportable oxygen concentrator. - A study on the activity and QOL of patients prescribed Long Term Oxygen Therapy which includes a transportable oxygen concentrator.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016376
Enrollment
42
Registered
2015-01-29
Start date
2015-01-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic respiratory failure patients who need LTOT

Interventions

Group A Using oxygen concentrators in order of 1. to 3. each by about a month. 1.transportable-&gt
2.stationary-&gt
3.semi-transportable Group B Using oxygen concentrators in order of 1. to 3. each by about a month. 1.semi-transportable-&gt
2.transportable-&gt
3.stationary Group C Using oxygen concentrators in order of 1. to 3. each by about a month. 1.stationary-&gt
2.semi-transportable-&gt
3.transportable Group D Using oxygen concentrators in order of 1. to 3. each by about a month. 1.transportable-&gt
3.stationary Group E Using oxygen concentrators in order of 1. to 3. each by about a month. 1.semi-transportable-&gt
3.transportable Group F Using oxygen concentrators in order of 1. to 3. each by about a month. 1.stationary-&gt
3.semi-transportable

Sponsors

Yokohama City University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The patients of chronic respiratory failure due to COPD etc. (2) The patients initially prescribed LTOT. (3)The patients who can walk alone and answer a questionnaire. (4) The patients who agreed to submit informed consent before this study.

Exclusion criteria

Exclusion criteria: (1) The patients with the prescription of oxygen dose more than 3L/min. (2) The patients whose treatment period of LTOT is expected to be less than three month. (3) The patients who has difficulty in answering questionnaire orally or by written. (4) The patients who are performed respiratory management by tracheotomy. (5) In addition, the patients who was judged as inappropriate for the candidate by a doctor.

Design outcomes

Primary

MeasureTime frame
Activity,QOL Definition: We adapt the form of the interval scale to the questionnaire vote, and take a score (5 points to 1 point) to every question. We set the value in the analysis item. The questions from No.1 to No.4 are about convenience. The questions from question No.5 to No.8 are about reassurance and safety. The questions from question No.9 to No.11 are about ecology and design. The questions from question No.12 to No.18 are about activity and QOL. The questions from question No.19 to No.20 are about sociality.

Secondary

MeasureTime frame
sociality convenience reassurance and safety ecology and design Definition: We adapt the form of the interval scale to the questionnaire vote, and take a score (5 points to 1 point) to every question. We set the value in the analysis item. The questions from No.1 to No.4 are about convenience. The questions from question No.5 to No.8 are about reassurance and safety. The questions from question No.9 to No.11 are about ecology and design. The questions from question No.12 to No.18 are about activity and QOL. The questions from question No.19 to No.20 are about sociality.

Countries

Japan

Contacts

Public ContactMasahiro Shinoda

Yokohama City University Medical Center Respiratory disease center

smarou@yokohama-cu.ac.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026